Stay updated on DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial

Sign up to get notified when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Publications section updated: added the final Nat Med 2026 article citation for High-dose nusinersen in SMA with full citation details (including DOI and publication date) and replaced the prior online-ahead-of-print citation.
    Difference
    0.1%
    Check dated 2026-04-16T11:00:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T17:58:01.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This change appears to be an internal version update that does not alter the study details or user-facing content on the page.
    Difference
    0.0%
    Check dated 2026-03-11T15:49:22.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added a Nat Med publication citation for a high-dose nusinersen phase 3 trial and updated the page revision to v3.4.2; the NIH funding-status notice was removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:16:52.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a general site operation notice about government funding and NIH Clinical Center status, and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T05:33:29.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    UI/metadata updates include showing the glossary, displaying the QC update status, capitalization tweaks, and a new page revision to v3.4.0; no core study content, endpoints, eligibility criteria, or safety data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T03:05:45.000Z thumbnail image

Stay in the know with updates to DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.